Samar Mowafy

Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives

Samar Mowafy, Athanasios Galanis, Zainab M. Doctor et al. · Bioorganic & Medicinal Chemistry · 2016 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation

Mahitab K. Sobhy, Samar Mowafy, Deena S. Lasheen et al. · Bioorganic Chemistry · 2019 · 53 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors

Samar Mowafy, Nahla A. Farag, Khaled A. M. Abouzid · European Journal of Medicinal Chemistry · 2012 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Structure-guided development of covalent TAK1 inhibitors

Li Tan, Deepak Gurbani, Ellen Weisberg et al. · Bioorganic & Medicinal Chemistry · 2016 · 35 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma

Ahmed I. Khodair, Salwa M. El‐Hallouty, Brittnee Cagle-White et al. · European Journal of Medicinal Chemistry · 2023 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +9